View Press Releases
-
University of Pittsburgh Selects GenomOncology to Support Research Efforts
WESTLAKE, OH - GenomOncology today announced that the University of Pittsburgh has selected GenomOncology's GenomAnalytics™ platform and services to explore and mine the breadth of data that exists in The Cancer Genome Atlas (TCGA) . Cancer is a complex disease of the genome with each tumor h
Feb 3, 2014
-
NHS awards significant cytogenetics tender to OGT
OXFORD, UK - Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has been awarded a significant tender by the UK National Health Service for the supply of oligo-based arrays for cytogenetics.
Feb 3, 2014
-
Insight Pharma Reports Announces Ocular Disorders: Rising Therapeutics, Technologies, and Devices
NEEDHAM, MA. - Cambridge Healthtech Institute's Insight Pharma Reports announces Ocular Disorders: Rising Therapeutics, Technologies, and Devices. The newly released Insight Pharma Report covers a handful of companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.
Jan 30, 2014
-
Cambridge Healthtech Institute Acquires the Knowledge Foundation Inc.
NEEDHAM, MA - Cambridge Healthtech Institute (CHI) announces today the acquisition of the Knowledge Foundation, Inc.
Jan 29, 2014
-
Insight Pharma Reports Announces Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor
NEEDHAM, MA - Insight Pharma Reports announces Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor report. The newly released Insight Pharma Report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare.
Jan 29, 2014
-
Miltenyi Biotec Receives FDA Approval for CliniMACS® CD34 Reagent System for Prevention of Graft-Versus-Host Disease in the Treatment of Acute Myeloid Leukemia
BERGISCH GLADBACH, GERMANY - Miltenyi Biotec announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease (GVHD) in patients with acute myeloid leukemia (AML) in first complete remission undergoing allogeneic stem cell transplantation (SCT) from a matched related donor
Feb 25, 2014
-
Insight Pharma Reports Announces Digital PCR Technology Report: An Insight to Vendors, Costs & the End User Community
NEEDHAM, MA - Cambridge Healthtech Institute's Insight Pharma Reports announces Digital PCR Technology Report: An Insight to Vendors, Costs & the End User Community.
Nov 30, 2013